Show simple item record

dc.contributor.authorBaines, Simon D.
dc.contributor.authorO'Connor, Rachel
dc.contributor.authorSaxton, Katie
dc.contributor.authorFreeman, Jane
dc.contributor.authorWilcox, M. H.
dc.identifier.citationBaines , S D , O'Connor , R , Saxton , K , Freeman , J & Wilcox , M H 2009 , ' Activity of vancomycin against epidemic Clostridium difficile strains in a human gut model ' , Journal of Antimicrobial Chemotherapy , vol. 63 , no. 3 , pp. 520-5 .
dc.identifier.otherPURE: 1351897
dc.identifier.otherPURE UUID: c47d0f32-5164-40c2-bcf6-2f6a181297af
dc.identifier.otherPubMed: 19112083
dc.identifier.otherScopus: 60649089055
dc.description.abstractVancomycin and metronidazole remain the only primary options for the treatment of Clostridium difficile infection (CDI). Recent reports have suggested a superior clinical response to vancomycin therapy compared with metronidazole, but this has been difficult to prove or explain. There are few robust in vitro data of the effects of antibiotic treatment of CDI in a gut reflective setting.en
dc.relation.ispartofJournal of Antimicrobial Chemotherapy
dc.titleActivity of vancomycin against epidemic Clostridium difficile strains in a human gut modelen
dc.contributor.institutionHealth & Human Sciences Research Institute
dc.contributor.institutionSchool of Life and Medical Sciences
dc.contributor.institutionDepartment of Human and Environmental Sciences
dc.contributor.institutionAgriculture, Food and Veterinary Sciences
dc.contributor.institutionGeography, Environment and Agriculture
dc.contributor.institutionMicrobiology and Biotechnology
dc.contributor.institutionDepartment of Biological and Environmental Sciences
dc.description.statusPeer reviewed
rioxxterms.typeJournal Article/Review

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record